These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 21806575

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.
    Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA.
    Clin Breast Cancer; 2005 Oct; 6(4):354-6. PubMed ID: 16277887
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios.
    Watson WJ.
    Obstet Gynecol; 2005 Mar; 105(3):642-3. PubMed ID: 15738038
    [Abstract] [Full Text] [Related]

  • 6. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios.
    Beale JM, Tuohy J, McDowell SJ.
    Am J Obstet Gynecol; 2009 Jul; 201(1):e13-4. PubMed ID: 19398090
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular subtype shift in breast cancer upon trastuzumab treatment: a case report.
    Āboliņš A, Vanags A, Trofimovičs G, Miklaševičs E, Gardovskis J, Štrumfa I.
    Pol J Pathol; 2011 Jul; 62(1):65-8. PubMed ID: 21574108
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].
    Nakajima H, Mizuta N, Mizuta M, Nakatsukasa K, Kobayashi A, Hachimine Y, Sakaguchi K, Fujiwara I, Sawai K.
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1305-8. PubMed ID: 16969030
    [Abstract] [Full Text] [Related]

  • 17. Treatment of breast cancer with trastuzumab during pregnancy.
    Pant S, Landon MB, Blumenfeld M, Farrar W, Shapiro CL.
    J Clin Oncol; 2008 Mar 20; 26(9):1567-9. PubMed ID: 18349415
    [No Abstract] [Full Text] [Related]

  • 18. [A long survival of a patient with poor performance status who suffered from advanced right breast cancer with multiple lung metastases controlled by trastuzumab as a key drug].
    Fujikawa T, Mukai K, Tanaka A, Abe T, Yoshimoto Y, Tada S, Maekawa H, Shimoike N, Tanaka H, Kawashima T, Yokota T.
    Gan To Kagaku Ryoho; 2012 Jun 20; 39(6):1009-12. PubMed ID: 22705704
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.
    Stemmler HJ, Kahlert S, Siekiera W, Untch M, Heinrich B, Heinemann V.
    Breast; 2006 Apr 20; 15(2):219-25. PubMed ID: 16026983
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.